Stephenson KE, Julg B, Tan CS, Zash R, et al. Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial. Nat Med 2021 Oct 7. pii: 10.1038/s41591-021-01509.
PMID: 34621054